Apolipoprotein E (apoE) levels in brains from Alzheimer disease patients and controls
Nenad Bogdanovic, Terho Lehtimäki
Brain Research, 1996
View PDFchevron_right
Apolipoprotein E isoforms in Alzheimer's disease pathology and etiology
Larry Baum
Microscopy Research and Technique, 2000
View PDFchevron_right
Apolipoprotein E metabolism and functions in brain and its role in Alzheimerʼs disease
Fan Liao
Current Opinion in Lipidology, 2016
View PDFchevron_right
Measurement of apolipoprotein E and amyloid β clearance rates in the mouse brain using bolus stable isotope labeling
Jungsu Kim
Molecular Neurodegeneration, 2012
View PDFchevron_right
Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer’s disease patients and controls
Henrietta Nielsen
Acta Neuropathologica, 2014
View PDFchevron_right
Opposite Roles of Apolipoprotein E in Normal Brains and in Alzheimer's Disease
claudio russo
Proceedings of The National Academy of Sciences, 1998
View PDFchevron_right
Mass Spectrometry Quantification Revealed Accumulation of C-Terminal Fragment of Apolipoprotein E in the Alzheimer's Frontal Cortex
Illarion Turko
PLoS ONE, 2013
View PDFchevron_right
Apolipoprotein E in Alzheimer's disease and other neurological disorders
Philip Verghese
The Lancet Neurology, 2011
View PDFchevron_right
The ability of apolipoprotein E fragments to promote intraneuronal accumulation of amyloid beta peptide 42 is both isoform and size-specific
IOANNIS DAFNIS
Scientific Reports, 2016
View PDFchevron_right
Apolipoprotein e: essential catalyst of the Alzheimer amyloid cascade
Huntington Potter
International journal of Alzheimer's disease, 2012
View PDFchevron_right
Apolipoprotein E and β-amyloid levels in the hippocampus and frontal cortex of Alzheimer's disease subjects are disease-related and apolipoprotein E genotype dependent
Caroline Petit-turcotte, Charles Ramassamy
Brain Research, 1999
View PDFchevron_right
Function and Comorbidities of Apolipoprotein E in Alzheimer's Disease
Judes Poirier
International Journal of Alzheimer's Disease, 2011
View PDFchevron_right
ApoE influences amyloid-β (Aβ) clearance despite minimal apoE/Aβ association in physiological conditions
carl frieden
Proceedings of the National Academy of Sciences, 2013
View PDFchevron_right
Quantification of total apolipoprotein E and its specific isoforms in cerebrospinal fluid and blood in Alzheimer’s disease and other neurodegenerative diseases
Ann Brinkmalm
EuPA Open Proteomics, 2015
View PDFchevron_right
The Role of Apolipoprotein E in Alzheimer's Disease
Jungsu Kim
Neuron, 2009
View PDFchevron_right
Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases
Robert Mahley
Neurobiology of disease, 2014
View PDFchevron_right
Apolipoprotein E and Alzheimer's disease: The protective effects of ApoE2 and E3
M. Kindy
Journal of Alzheimer's Disease, 2002
View PDFchevron_right
ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies
Zachary Trottier
Molecular Neurodegeneration
View PDFchevron_right
Apolipoprotein E imbalance in the cerebrospinal fluid of Alzheimer’s disease patients
Javier Sáez-Valero
Alzheimer's Research & Therapy, 2022
View PDFchevron_right
Apolipoprotein E, Amyloid, and Alzheimer Disease
JC Dodart
Molecular Interventions, 2002
View PDFchevron_right
A Multi-Cohort Study of ApoE ɛ4 and Amyloid-β Effects on the Hippocampus in Alzheimer's Disease
Patrizia Mecocci
Journal of Alzheimer's disease : JAD, 2017
View PDFchevron_right
Binding of Human Apolipoprotein E to Synthetic Amyloid Beta Peptide: Isoform-Specific Effects and Implications for Late-Onset Alzheimer Disease
Dong Li
Proceedings of the …, 1993
View PDFchevron_right
Apolipoprotein E as a β-amyloid-independent factor in Alzheimer’s disease
Jungsu Kim
Alzheimer's Research & Therapy, 2013
View PDFchevron_right
ApoE influences amyloid- (A ) clearance despite minimal apoE/A association in physiological conditions
Philip Verghese
Proceedings of the National Academy of Sciences, 2013
View PDFchevron_right
Are apolipoprotein E fragments a promising new therapeutic target for Alzheimer’s disease?
Madia LOZUPONE
Therapeutic Advances in Chronic Disease, 2022
View PDFchevron_right
Genotype-related differences of hippocampal apolipoprotein E levels only in early stages of neuropathological changes in Alzheimer’s disease
Max Mesk
Neuroscience, 2002
View PDFchevron_right
Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer’s amyloid β peptides
ruben vidal
Biochemical Journal, 2000
View PDFchevron_right
Apolipoprotein E level and cholesterol are associated with reduced synaptic amyloid beta in Alzheimer’s disease and apoE TR mouse cortex
Wayne Poon
Acta Neuropathologica, 2012
View PDFchevron_right
Apolipoprotein E represents a potent gene-based therapeutic target for the treatment of sporadic Alzheimer’s disease
Judes Poirier
Alzheimer's & Dementia, 2008
View PDFchevron_right